PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
EAR vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between EAR and PFE is -0.00. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0
Correlation: -0.0

Performance

EAR vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Eargo, Inc. (EAR) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2025FebruaryMarchApril
-99.62%
-24.73%
EAR
PFE

Key characteristics

Fundamentals

Market Cap

EAR:

$53.36M

PFE:

$125.57B

EPS

EAR:

$15.00

PFE:

$1.41

PE Ratio

EAR:

0.17

PFE:

15.70

PS Ratio

EAR:

1.30

PFE:

1.97

PB Ratio

EAR:

1.18

PFE:

1.42

Returns By Period


EAR

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

PFE

YTD

-15.17%

1M

-15.46%

6M

-21.78%

1Y

-9.51%

5Y*

-4.20%

10Y*

0.00%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

EAR vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EAR

PFE
The Risk-Adjusted Performance Rank of PFE is 3636
Overall Rank
The Sharpe Ratio Rank of PFE is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 3030
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 3131
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 4545
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 4040
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

EAR vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Eargo, Inc. (EAR) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
No data
The chart of Calmar ratio for EAR, currently valued at 0.00, compared to the broader market0.001.002.003.004.00
EAR: 0.00
PFE: -0.14


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00NovemberDecember2025FebruaryMarchApril
-1.00
-0.35
EAR
PFE

Dividends

EAR vs. PFE - Dividend Comparison

EAR has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 7.63%.


TTM20242023202220212020201920182017201620152014
EAR
Eargo, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
7.63%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%

Drawdowns

EAR vs. PFE - Drawdown Comparison


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%NovemberDecember2025FebruaryMarchApril
-99.83%
-57.92%
EAR
PFE

Volatility

EAR vs. PFE - Volatility Comparison

The current volatility for Eargo, Inc. (EAR) is 0.00%, while Pfizer Inc. (PFE) has a volatility of 9.66%. This indicates that EAR experiences smaller price fluctuations and is considered to be less risky than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%2.00%4.00%6.00%8.00%10.00%NovemberDecember2025FebruaryMarchApril0
9.66%
EAR
PFE

Financials

EAR vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Eargo, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab